BSX stock page - price, fundamentals, dividends - iOCharts

BSX

45.51
+1.54 (3.50%)
Boston Scientific Corporation (NYSE, USD)
Healthcare >
Medical Devices
Market cap
64.65B
Ent value
77.81B
Price/Sales
6.52
Price/Book
4.11
Div yield
-
Div growth
-
Growth years
-
FCF payout
4.95%
Trailing P/E
-
Forward P/E
24.73
PEG
-
EPS growth
108.20%
1 year return
18.67%
3 year return
9.86%
5 year return
13.94%
10 year return
20.45%
Last updated: 2021-07-28

STOCK INFORMATION

Stock chart
Loading...
Stock price data
All-time high45.81
1y analyst estimate48.97
Beta0.84
EPS (TTM)-0.06
Dividend per share-
Ex-div date-
Next earnings date27 Jul 2021
Downside potential
Loading...
Downside potential data
BSXS&P500
Current price drop from All-time high-0.65%-0.46%
Highest price drop-89.15%-56.47%
Date of highest drop26 Jul 20129 Mar 2009
Avg drop from high-43.91%-11.53%
Avg time to new high46 days13 days
Max time to new high4358 days1805 days

DIVIDENDS

BSX does not pay dividends

FINANCIALS

Per share
Loading...
Per share data
Current share count1.42B
EPS (TTM)-0.06
FCF per share (TTM)0.80
Income statement
Loading...
Income statement data
Revenue (TTM)9.91B
Gross profit (TTM)6.45B
Operating income (TTM)684.00M
Net income (TTM)-81.00M
EPS (TTM)-0.06
EPS (1y forward)1.84
Margins
Loading...
Margins data
Gross margin (TTM)65.04%
Operating margin (TTM)6.90%
Profit margin (TTM)-0.82%
Balance Sheet
Loading...

Please create a free account or log in to access this chart

Balance Sheet data
Cash2.02B
Net receivables1.63B
Total current assets6.10B
Goodwill10.87B
Intangible assets5.99B
Property, plant and equipment2.46B
Total assets30.90B
Accounts payable2.67B
Short/Current long term debt9.08B
Total current liabilities3.39B
Total liabilities15.18B
Shareholder's equity15.72B
Net tangible assets-1.14B
Cash flow
Loading...

Please create a free account or log in to access this chart

Cash flow data
Operating cash flow (TTM)1.51B
Capital expenditures (TTM)376.00M
Free cash flow (TTM)1.13B
Dividends paid (TTM)56.00M
Financial returns
Loading...

Please create a free account or log in to access this chart

Financial returns data
Return on Equity-0.53%
Return on Assets-0.26%
Return on Invested Capital-0.33%
Cash Return on Invested Capital4.63%
COMPANY DETAILS
BSX (Boston Scientific Corporation) company logo
Marketcap
64.65B
Marketcap category
Large-cap
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Employees
38000
SEC filings
CEO
Michael Mahoney
Country
USA
City
Marlborough
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Loading...